Clearmind Medicine, Inc. (CMND)
0.92
-0.05
(-4.83%)
USD |
NASDAQ |
Sep 14, 16:00
0.92
0.00 (0.00%)
After-Hours: 17:31
Clearmind Medicine Shareholders Equity (Quarterly) : 12.95M for July 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | 12.95M |
| April 30, 2026 | 11.49M |
| January 31, 2026 | 8.238M |
| October 31, 2025 | 1.193M |
| July 31, 2025 | 1.066M |
| April 30, 2025 | 2.302M |
| January 31, 2025 | 2.854M |
| October 31, 2024 | 3.108M |
| July 31, 2024 | 3.473M |
| April 30, 2024 | 4.646M |
| January 31, 2024 | 5.041M |
| October 31, 2023 | 0.9835M |
| July 31, 2023 | 2.828M |
| April 30, 2023 | 3.342M |
| January 31, 2023 | 3.854M |
| October 31, 2022 | -1.107M |
| July 31, 2022 | 0.2836M |
| April 30, 2022 | 1.431M |
| Date | Value |
|---|---|
| January 31, 2022 | 2.412M |
| October 31, 2021 | 3.874M |
| July 31, 2021 | 5.305M |
| April 30, 2021 | 1.574M |
| January 31, 2021 | 0.3137M |
| October 31, 2020 | 0.3745M |
| July 31, 2020 | 0.4288M |
| April 30, 2020 | 0.4645M |
| January 31, 2020 | 0.0823M |
| October 31, 2019 | 0.1018M |
| July 31, 2019 | 0.1209M |
| April 30, 2019 | 0.1342M |
| January 31, 2019 | 0.1652M |
| October 31, 2018 | 0.1821M |
| July 31, 2018 | 0.1427M |
| April 30, 2018 | 0.1802M |
| January 31, 2018 | 0.1924M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 1.075M |
| NervGen Pharma Corp. | 12.18M |
| Milestone Pharmaceuticals, Inc. | 18.22M |
| Lexaria Bioscience Corp. | 4.738M |
| Target Group, Inc. (Canada) | -8.655M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.91M |
| Total Liabilities (Quarterly) | 3.961M |
| Debt to Equity Ratio | 0.1389 |
| Current Ratio | 4.309 |
| Net Debt Paydown Yield | -9.72% |